Shi J

ORCID: 0000-0003-4261-6818 · 128 papers in corpus
2023
BMC pregnancy and childbirth ·doi:10.1186/s12884-023-05880-3

BackgroundHydrosalpinx may decrease implantation and pregnancy rates after embryo transfer. Laparoscopic tubal ligation after embryo freeze and before frozen-thawed embryo transfer (FET) is effective at improving reproductive outcomes for h…

2023
Journal of nanobiotechnology ·doi:10.1186/s12951-023-01834-1

Most pregnancy losses worldwide are caused by implantation failure for which there is a lack of effective therapeutics. Extracellular vesicles are considered potential endogenous nanomedicines because of their unique biological functions. H…

2022
Endocrine connections ·doi:10.1530/ec-21-0444

ObjectiveVitamin D receptors are present in the female reproductive tract. Studies on the association between serum vitamin D level and pregnancy rate of in vitro fertilization (IVF) showed inconsistent results and focused on a single fresh…

2022
JAMA network open ·doi:10.1001/jamanetworkopen.2022.36609

ImportanceThere is a lack of information regarding the need to postpone conception after COVID-19 vaccination.ObjectiveTo investigate the time interval between the first dose of inactivated COVID-19 vaccine and in vitro fertilization (IVF) …

article 2022
BMC women's health ·doi:10.1186/s12905-022-02068-3

BACKGROUND: This retrospective study evaluated the clinical features of perineal endometriosis (PEM) and established a prognostic nomogram for recurrence probability in patients treated with surgical resection. METHODS: This study enrolled…

article 2022
BMC pregnancy and childbirth ·doi:10.1186/s12884-022-05276-9

BACKGROUND: Plenty of studies explored the most optimal treatment protocol for infertile women with adenomyosis in in-vitro fertilization (IVF) /intracytoplasmic sperm injection (ICSI), however, there is still no consensus on which treatmen…

erratum 2022
BMC women's health ·doi:10.1186/s12905-022-02100-6
article 2022
Frontiers in medicine ·doi:10.3389/fmed.2022.905688

BACKGROUND: To examine and compare the differences in clinical characteristics and long-term postoperative outcomes of ovarian endometriomas (OMA) patients with and without dysmenorrhea, including data from at least 8 years of postoperative…

2022
BMC women's health ·doi:10.1186/s12905-022-02062-9

BackgroundIntracytoplasmic sperm injection (ICSI) is increasingly used among in vitro fertilization (IVF) cycles without male factor infertility. For couples with prolonged infertility duration, the preferred insemination method may vary ac…

2022
Frontiers in medicine ·doi:10.3389/fmed.2022.938606

AimThis systematic review aimed to assess the efficacy and safety of Drospirenone and Ethinylestradiol Tablets (II) in the treatment of dysmenorrhea.MethodsElectronic databases, namely PubMed, Embase, Cochrane Controlled Register of Trials …

article 2022
Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology ·doi:10.1080/01443615.2022.2106559

This study aimed to investigate the effect of early inflammatory reaction on ovarian reserve of patients with ovarian endometriomas after laparoscopic cystectomy. Our retrospective case series included 112 patients with ovarian endometrioma…

other 2022
BMC pregnancy and childbirth ·doi:10.1186/s12884-021-04342-y

BACKGROUND: Intrauterine insemination (IUI) treatment is recommended in subfertile women with AFS/ASRM stage I/II endometriosis. However, the efficacy of IUI in women with ovarian endometriomas with tubal patency is uncertain. We explored t…

article 2022
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-022-00897-3

BACKGROUND: To determine whether gonadotropin-releasing hormone (GnRH) agonist downregulation combined with hormone replacement therapy (HRT) can improve the reproductive outcomes in frozen-thawed embryo transfer cycles for older patients (…

preprint 2022
·doi:10.22541/au.165276725.52323745/v1

Background: Adenomyosis (AM) is a common benign gynaecologic disease characterized by dysmenorrhea and heavy menstrual bleeding and requires for long-term management. Levonorgestrel - releasing Intrauterine System (LNG-IUS) is a long-acting…

2022
Frontiers in endocrinology ·doi:10.3389/fendo.2022.969379

BackgroundA number of studies have compared the clinical outcomes between the two endometrial preparation methods: natural cycles (NCs) and hormone replacement treatment (HRT) before frozen embryo transfer, but the results were conflicting.…

2022
Frontiers in endocrinology ·doi:10.3389/fendo.2022.900829

ObjectivePredictive models of the cumulative live birth (CLB) in women undergoing in vitro fertilization (IVF) treatment are limited. The aim of this study was to develop and validate a nomogram for the CLB in women undergoing the first IVF…

other 2022
Fertility and sterility ·doi:10.1016/j.fertnstert.2022.08.856

OBJECTIVE: To review the use of oral gonadotropin-releasing hormone (GnRH) antagonists and synthesize their efficacy and safety parameters for the treatment of endometriosis-associated pain. DESIGN: Systematic review and network meta-analy…

article 2022
Archives of gynecology and obstetrics ·doi:10.1007/s00404-022-06579-0

PurposeTo classify abdominal wall endometriosis (AWE) according to the invasive levels of tissue mass, and to compare the differences in clinical characteristics between different types of AWE.MethodsIn this study, we retrospectively analyz…

article 2022
Frontiers in medicine ·doi:10.3389/fmed.2022.872481

OBJECTIVE: This study aimed to establish an effective prognostic nomogram for the postoperative recurrence of endometrioma or endometriosis-related pain for patients with endometrioma after long-term follow-up, who were younger than 45 year…

2022
Frontiers in endocrinology ·doi:10.3389/fendo.2022.1062303

Research questionIs there an association between intrauterine hematoma (IUH), vanishing twin syndrome (VTS), and subsequent complications in twin pregnancies after in vitro fertilization (IVF)? What are the risk factors for these complicati…

preprint 2021
·doi:10.21203/rs.3.rs-601588/v1

Abstract Purpose To classify abdominal wall endometriosis (AWE) according to the invasive levels of tissue mass, and to compare the differences in clinical characteristics between different types of AWE. Methods In this study, we retrospect…

preprint 2021
·doi:10.21203/rs.3.rs-930037/v1

Abstract Background : Intrauterine insemination (IUI) treatment is recommended in subfertile women with AFS/ASRM stage I/II endometriosis. However, the efficacy of IUI in women with ovarian endometriomas with tubal patency is uncertain. We …

article 2021
Frontiers in reproductive health ·doi:10.3389/frph.2021.711123

Epidemiological studies have observed that risk of endometriosis is associated with history of cutaneous melanoma and vice versa. Evidence for shared biological mechanisms between the two traits is limited. The aim of this study was to inve…

preprint 2021
·doi:10.21203/rs.3.rs-1090205/v1

Abstract BackgroundTo determine whether Gonadotropin-releasing hormone (GnRH) agonist down regulation combined with hormone replacement treatment (HRT) can improve the reproductive outcomes in the frozen thawed embryo transfer (FET) cycle o…

article 2021
Frontiers in immunology ·doi:10.3389/fimmu.2021.671201

Endometriosis is an oestrogen-dependent chronic inflammatory process with primary symptoms including dysmenorrhea, chronic pelvic pain, and infertility. The immune environment of the endometrium is essential for successful embryo implantati…